Topvision Eye Specialist Berhad (TOPVISN) Stock Overview
An investment holding company, engages in the provision of ophthalmology and related medical consultancy services in Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
TOPVISN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Topvision Eye Specialist Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.15 |
| 52 Week High | RM 0.26 |
| 52 Week Low | RM 0.15 |
| Beta | -0.11 |
| 1 Month Change | -8.82% |
| 3 Month Change | -18.42% |
| 1 Year Change | -29.55% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -32.61% |
Recent News & Updates
Recent updates
Topvision Eye Specialist Berhad (KLSE:TOPVISN) Might Be Having Difficulty Using Its Capital Effectively
Jan 06
Here's What's Concerning About Topvision Eye Specialist Berhad's (KLSE:TOPVISN) Returns On Capital
Aug 22A Look At The Intrinsic Value Of Topvision Eye Specialist Berhad (KLSE:TOPVISN)
May 13Market Still Lacking Some Conviction On Topvision Eye Specialist Berhad (KLSE:TOPVISN)
Apr 16Is Topvision Eye Specialist Berhad (KLSE:TOPVISN) Using Too Much Debt?
Feb 19Shareholder Returns
| TOPVISN | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | -3.1% | 1.9% | -0.2% |
| 1Y | -29.5% | 26.5% | 10.8% |
Return vs Industry: TOPVISN underperformed the MY Healthcare industry which returned 26.5% over the past year.
Return vs Market: TOPVISN underperformed the MY Market which returned 10.8% over the past year.
Price Volatility
| TOPVISN volatility | |
|---|---|
| TOPVISN Average Weekly Movement | 6.6% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in MY Market | 11.0% |
| 10% least volatile stocks in MY Market | 2.5% |
Stable Share Price: TOPVISN has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: TOPVISN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Peter Chong | www.tvesc.com |
Topvision Eye Specialist Berhad, an investment holding company, engages in the provision of ophthalmology and related medical consultancy services in Malaysia. The company offers various eye care services comprising cataract, diabetic retinopathy, vitreous and retinal diseases, glaucoma, corneal, anterior segment diseases, age-related macular degeneration, pterygium, dry eyes, lid disorder, children's eye disorder services, and other external eye problems, as well as eye examination, investigation, and refraction services. It also engages in the marketing of eye supplements and health food products, as well as retail sale of food and beverage.
Topvision Eye Specialist Berhad Fundamentals Summary
| TOPVISN fundamental statistics | |
|---|---|
| Market cap | RM 48.02m |
| Earnings (TTM) | RM 1.90m |
| Revenue (TTM) | RM 45.81m |
Is TOPVISN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TOPVISN income statement (TTM) | |
|---|---|
| Revenue | RM 45.81m |
| Cost of Revenue | RM 22.94m |
| Gross Profit | RM 22.87m |
| Other Expenses | RM 20.97m |
| Earnings | RM 1.90m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0061 |
| Gross Margin | 49.92% |
| Net Profit Margin | 4.15% |
| Debt/Equity Ratio | 27.0% |
How did TOPVISN perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/13 23:55 |
| End of Day Share Price | 2026/03/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Topvision Eye Specialist Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.